These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1097 related articles for article (PubMed ID: 26974331)

  • 61. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
    Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
    Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Restoration of pharyngeal dilator muscle force in dystrophin-deficient (mdx) mice following co-treatment with neutralizing interleukin-6 receptor antibodies and urocortin 2.
    Burns DP; Rowland J; Canavan L; Murphy KH; Brannock M; O'Malley D; O'Halloran KD; Edge D
    Exp Physiol; 2017 Sep; 102(9):1177-1193. PubMed ID: 28665499
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunohistochemical staining of dystrophin on formalin-fixed paraffin-embedded sections in Duchenne/Becker muscular dystrophy and manifesting carriers of Duchenne muscular dystrophy.
    Hoshino S; Ohkoshi N; Watanabe M; Shoji S
    Neuromuscul Disord; 2000 Aug; 10(6):425-9. PubMed ID: 10899449
    [TBL] [Abstract][Full Text] [Related]  

  • 65. L-type Ca2+ channel function is linked to dystrophin expression in mammalian muscle.
    Friedrich O; von Wegner F; Chamberlain JS; Fink RH; Rohrbach P
    PLoS One; 2008 Mar; 3(3):e1762. PubMed ID: 18516256
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Large in-frame 5' deletions in DMD associated with mild Duchenne muscular dystrophy: Two case reports and a review of the literature.
    Gibbs EM; Barthélémy F; Douine ED; Hardiman NC; Shieh PB; Khanlou N; Crosbie RH; Nelson SF; Miceli MC
    Neuromuscul Disord; 2019 Nov; 29(11):863-873. PubMed ID: 31672265
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
    Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
    Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
    Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
    Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy.
    Scaglioni D; Catapano F; Ellis M; Torelli S; Chambers D; Feng L; Beck M; Sewry C; Monforte M; Harriman S; Koenig E; Malhotra J; Popplewell L; Guglieri M; Straub V; Mercuri E; Servais L; Phadke R; Morgan J; Muntoni F
    Acta Neuropathol Commun; 2021 Jan; 9(1):7. PubMed ID: 33407808
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.
    Grady RM; Teng H; Nichol MC; Cunningham JC; Wilkinson RS; Sanes JR
    Cell; 1997 Aug; 90(4):729-38. PubMed ID: 9288752
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inactivation of Sirt6 ameliorates muscular dystrophy in mdx mice by releasing suppression of utrophin expression.
    Georgieva AM; Guo X; Bartkuhn M; Günther S; Künne C; Smolka C; Atzberger A; Gärtner U; Mamchaoui K; Bober E; Zhou Y; Yuan X; Braun T
    Nat Commun; 2022 Jul; 13(1):4184. PubMed ID: 35859073
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
    Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
    J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunohistochemistry of sarcolemmal membrane-associated proteins in formalin-fixed and paraffin-embedded skeletal muscle tissue: a promising tool for the diagnostic evaluation of common muscular dystrophies.
    Suriyonplengsaeng C; Dejthevaporn C; Khongkhatithum C; Sanpapant S; Tubthong N; Pinpradap K; Srinark N; Waisayarat J
    Diagn Pathol; 2017 Feb; 12(1):19. PubMed ID: 28219397
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle.
    Wells KE; Torelli S; Lu Q; Brown SC; Partridge T; Muntoni F; Wells DJ
    Neuromuscul Disord; 2003 Jan; 13(1):21-31. PubMed ID: 12467729
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
    Mizuno Y; Nonaka I; Hirai S; Ozawa E
    J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
    Banks GB; Chamberlain JS
    Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Functional substitution by TAT-utrophin in dystrophin-deficient mice.
    Sonnemann KJ; Heun-Johnson H; Turner AJ; Baltgalvis KA; Lowe DA; Ervasti JM
    PLoS Med; 2009 May; 6(5):e1000083. PubMed ID: 19478831
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice.
    Tjondrokoesoemo A; Schips TG; Sargent MA; Vanhoutte D; Kanisicak O; Prasad V; Lin SC; Maillet M; Molkentin JD
    J Biol Chem; 2016 May; 291(19):9920-8. PubMed ID: 26966179
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interleukin-6 and neuregulin-1 as regulators of utrophin expression via the activation of NRG-1/ErbB signaling pathway in mdx cells.
    Juretić N; Díaz J; Romero F; González G; Jaimovich E; Riveros N
    Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):770-780. PubMed ID: 27988307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.